Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Rogler

Showing results (141-150 of 547) with videos related to

Pageof 55
Sort By:
Inflammatory Intestinal Diseases|September 18, 2018
Eribulin Does Not Prevent Epithelial-to-Mesenchymal Transition in HT-29 Intestinal Epithelial CellsMartin Leutenegger, Ramona Bruckner, Marianne R Spalinger, et al.
Digestion|April 27, 2026
IL-22 associates with Venous Thromboembolism in Inflammatory Bowel Disease: A Hypothesis-Generating StudyRahel Cola, Gerhard Rogler, Luc Biedermann, et al.
International Journal of Colorectal Disease|January 28, 2004
Optimising the diagnostic value of anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohn's diseaseFrank H Klebl, Frauke Bataille, Ferdinand Hofstädter, et al.
International Journal of Molecular Sciences|August 28, 2025
Unraveling the Converging Roles of ASC-Dependent Inflammasomes, Interleukin-1 Superfamily Members, Serum Amyloid A, and Non-Sterile Inflammation in Disease Pathology and Fibrosis in Inflammatory Bowel Disease and Primary Sclerosing CholangitisMarco Losa, Marlene Schwarzfischer, Marc Emmenegger, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|May 4, 2007
A case of recurrent gastrointestinal bleeding and protein-losing gastroenteropathyHans Herfarth, Ferdinand Hofstädter, Stefan Feuerbach, et al.
European Journal of Gastroenterology & Hepatology|March 10, 2005
Crohn's disease patient characteristics in a tertiary referral center: comparison with patients from a population-based cohortEike Zankel, Gerhard Rogler, Tilo Andus, et al.
Digestion|August 18, 2015
Serum REG3alpha and C-Reactive Protein Levels in Crohn's Disease Patients Undergoing Immunoablation and Autologous Hemopoetic Stem Cell Transplantation in the ASTIC TrialThomas Greuter, Silvia Lang, Ernst Holler, et al.
The American Journal of Gastroenterology|October 19, 2002
Improvement of arthritis and arthralgia after treatment with infliximab (Remicade) in a German prospective, open-label, multicenter trial in refractory Crohn's diseaseHans Herfarth, Florian Obermeier, Tilo Andus, et al.
Medicina (Kaunas, Lithuania)|July 27, 2024
Long-Term Outcome of Surgery for Perianal Crohn's FistulaMarie Schaad, Alain Schoepfer, Jean-Benoît Rossel, et al.
Inflammatory Bowel Diseases|February 23, 2013
A shift from oral to intravenous iron supplementation therapy is observed over time in a large swiss cohort of patients with inflammatory bowel diseaseStephan R Vavricka, Alain M Schoepfer, Ekaterina Safroneeva, et al.
Pageof 55

Showing results (141-150 of 547) with videos related to

Sort By:
Pageof 55
Inflammatory Intestinal Diseases|September 18, 2018
Eribulin Does Not Prevent Epithelial-to-Mesenchymal Transition in HT-29 Intestinal Epithelial CellsMartin Leutenegger, Ramona Bruckner, Marianne R Spalinger, et al.
Digestion|April 27, 2026
IL-22 associates with Venous Thromboembolism in Inflammatory Bowel Disease: A Hypothesis-Generating StudyRahel Cola, Gerhard Rogler, Luc Biedermann, et al.
International Journal of Colorectal Disease|January 28, 2004
Optimising the diagnostic value of anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohn's diseaseFrank H Klebl, Frauke Bataille, Ferdinand Hofstädter, et al.
International Journal of Molecular Sciences|August 28, 2025
Unraveling the Converging Roles of ASC-Dependent Inflammasomes, Interleukin-1 Superfamily Members, Serum Amyloid A, and Non-Sterile Inflammation in Disease Pathology and Fibrosis in Inflammatory Bowel Disease and Primary Sclerosing CholangitisMarco Losa, Marlene Schwarzfischer, Marc Emmenegger, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|May 4, 2007
A case of recurrent gastrointestinal bleeding and protein-losing gastroenteropathyHans Herfarth, Ferdinand Hofstädter, Stefan Feuerbach, et al.
European Journal of Gastroenterology & Hepatology|March 10, 2005
Crohn's disease patient characteristics in a tertiary referral center: comparison with patients from a population-based cohortEike Zankel, Gerhard Rogler, Tilo Andus, et al.
Digestion|August 18, 2015
Serum REG3alpha and C-Reactive Protein Levels in Crohn's Disease Patients Undergoing Immunoablation and Autologous Hemopoetic Stem Cell Transplantation in the ASTIC TrialThomas Greuter, Silvia Lang, Ernst Holler, et al.
The American Journal of Gastroenterology|October 19, 2002
Improvement of arthritis and arthralgia after treatment with infliximab (Remicade) in a German prospective, open-label, multicenter trial in refractory Crohn's diseaseHans Herfarth, Florian Obermeier, Tilo Andus, et al.
Medicina (Kaunas, Lithuania)|July 27, 2024
Long-Term Outcome of Surgery for Perianal Crohn's FistulaMarie Schaad, Alain Schoepfer, Jean-Benoît Rossel, et al.
Inflammatory Bowel Diseases|February 23, 2013
A shift from oral to intravenous iron supplementation therapy is observed over time in a large swiss cohort of patients with inflammatory bowel diseaseStephan R Vavricka, Alain M Schoepfer, Ekaterina Safroneeva, et al.
Pageof 55